Recipients of ACCP’s 2023 national awards will be recognized in ceremonies starting today at 8:00 a.m. CST. For a detailed schedule of today’s ceremony, click here: https://www.accp.com/meetings/am23/schedule.aspx?mode=detail&i=11317.
BoucherBradley A. Boucher, Pharm.D., MCCM, FCCP, FNAP, has been chosen by the Parker Medal Selection Committee as the 2023 recipient of the College’s Paul F. Parker Medal for Distinguished Service to the Profession of Pharmacy. At the time of his nomination, Boucher was serving as interim dean at the University of Tennessee Health Science Center (UTHSC) College of Pharmacy. Immediately before holding the position of interim dean, he served as associate dean for Institutional Initiatives and Operations at UTHSC College of Pharmacy.
Paul Parker was one of clinical pharmacy’s most influential proponents. Before his death in 1998, Parker spent 24 years as director of pharmacy at the Chandler Medical Center/University of Kentucky in Lexington. His innovations included developing decentralized pharmacy services, placing pharmacists in the hospital’s clinical areas, and developing the nation’s first pharmacist-staffed drug information center. Parker’s vision for pharmacy practice was passed along to the more than 150 residents and fellows who trained in the Kentucky program during his tenure. These disciples included many of today’s leaders in clinical pharmacy who continue to pass along his wisdom and vision to their trainees and colleagues. The Paul F. Parker Medal recognizes an individual who has made outstanding and sustained contributions to the profession that improve patient or service outcomes, create innovative practices, affect patient populations, further the professional role of pharmacists, or expand the recognition of pharmacists as health professionals.
The Parker Medal Selection Committee chose Boucher as the 2023 medalist on the basis of his longstanding commitment to the pharmacy profession as an educator, clinician, and scholar.
Dr. Michael Kraft, a clinical professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy, wrote in his letter supporting Boucher’s nomination: “Considering his contributions to direct patient care, scientific literature, and the profession through professional organizations like ACCP, and the number of students and trainees he has mentored, his impact on the profession and patient care is arguably immeasurable,” adding: “He embodied the clinician dedicated to patient care who set high expectations for students and trainees.”
In his letter of support, Dr. Joseph Swanson, professor in the Department of Clinical Pharmacy and Translational Science and assistant director of Experiential Learning and International Programs at UTHSC College of Pharmacy, wrote:
Dr. Boucher’s significant contributions to the medical literature are enviable. He has published over 120 manuscripts and 36 book chapters and has edited 13 books. The significance of his publications has resulted in improvements to the care of critically injured trauma patients and his manuscripts have been cited by clinical practice guidelines. The scope of his expertise is as impressive as the depth. He has published in areas including, but not limited to, hemostasis, traumatic brain injury, infectious complications in critically ill patients, and pharmacokinetic changes in the critically ill.
Dr. Boucher’s sustained contributions to pharmacy organizations have helped to shape our profession. He led the Rho Chi Society as national President. His noteworthy contributions to the American College of Clinical Pharmacy (ACCP) are too numerous to list but include serving as Treasurer and President. More important than the titles he held is the leadership he provided. He has been elected as a Fellow in both ACCP and the American College of Critical Care Medicine. Dr. Boucher is one of only nine pharmacists in the world to have been honored with the status of Master of Critical Care Medicine, an honor that requires international recognition of one’s clinical, scholarly, and service contributions.
In his supporting letter, Dr. Curtis Haas, chief pharmacy officer at the University of Rochester in Rochester, New York, wrote:
As a career-long academic pharmacist, Dr. Boucher has made sustained and significant contributions to pharmacy education and training, especially in the area of critical care pharmacy. He has maintained a clinical pharmacy practice site in neurotrauma intensive care for nearly forty years, and over that span of time has precepted hundreds of pharmacy students, medical students and other trainees. He has trained 9 critical care fellows, the majority of whom have gone on to have distinguished careers in clinical practice, research, academia, or industry. He co-founded a critical care specialty residency (PGY-2), and as a faculty member in that program has contributed to the training of more than 78 residents to date. This represents the largest number of critical care pharmacy trainees from a single residency program in the country. Many of the graduates of the program are widely recognized as leaders of critical care pharmacy practice, research, and education in the US.
His many invited lectures and scientific presentations reflect the evolution of critical care pharmacy practice over several decades with nearly every area of therapeutic controversy over the years represented. He has been sought out for many years to speak on these topics because of his recognized expertise in critical care therapeutics and bedside practice. His receipt of fellowship recognition in clinical pharmacy and critical care were based upon his excellence in clinical practice. He received the ACCP Clinical Practice Award in 2011 and the ACCP Critical Care PRN Achievement Award in 2017. The National Academies of Practice in Pharmacy recognized Brad as a Distinguished Practitioner and Fellow in 2004 and he was recently honored with the Robert G. Leonard Memorial Lecture Award in 2022.
During its deliberations, committee members noted that Boucher has made outstanding, significant, and sustained contributions to improving or expanding the profession of pharmacy. These contributions – not limited to scientific research – have helped advance the pharmacy profession and improve patient outcomes. Furthermore, his work reflects a lifetime record of contributions. He will be recognized at the Awards and Recognition Ceremony during the 2023 ACCP Annual Meeting in Dallas, Texas. The ceremony will be held Sunday morning, November 12.
The Parker Medal Selection Committee is composed of leaders from member organizations of the Joint Commission of Pharmacy Practitioners, together with past presidents of ACCP. Members of the 2023 selection committee were Terry Seaton (chair), Nancy Alvarez, John Armitstead, Jean-Venable “Kelly” Goode, Thomas Hardin, Judith Jacobi, Jill Kolesar, J. Robert Powell, Steven Scott, and Janet Silvester.
BoylanThe ACCP New Educator Award recognizes and honors a new educator for outstanding contributions to the discipline of teaching and to the education of health care practitioners. The awardee must have been a Full Member of ACCP at the time of nomination and a member at any level for a minimum of 3 years; in addition, the awardee must have completed their terminal training or degree less than 6 years previously. Paul M. Boylan, Pharm.D., BCPS, is an assistant professor of pharmacy practice at the University of Oklahoma College of Pharmacy (OUCOP) and serves as a clinical pharmacist at The University of Oklahoma Medical Center. Previously, Boylan was an assistant professor at Larkin University College of Pharmacy (LUCOP), where he practiced as a clinical pharmacist at Larkin Community Hospital – Palm Springs Campus. Boylan received his Pharm.D. degree from Wilkes University Nesbitt School of Pharmacy and completed residency training at Reading Hospital in West Reading, Pennsylvania (PGY1), and Nova Southeastern University College of Pharmacy in Fort Lauderdale, Florida (PGY2, transitions of care).
The Awards Committee noted in its report to the ACCP Board of Regents:
In terms of classroom innovation, Dr. Boylan has utilized techniques such as remote asynchronous lectures with adaptive learning and the flipped-classroom model. Additionally, he has authored 16 peer-reviewed publications and 1 book chapter and serves as co-investigator on a major grant focused on adult community-acquired pneumonia. Dr. Boylan was recognized in 2019 as the Class of 2021 Teacher of the Year at LUCOP and as the 2021 Most Collegial Faculty Member, Class 2022 Educator of the Year, and 2022 Outstanding Educator at OUCOP. He was also awarded the 2022 Education and Training PRN Teaching and Mentoring Award. Dr. Boylan’s colleagues describe him as a “bright, creative, and scholarly academician” and his students as “highly empathetic, very receptive, and student-centered.” Dr. Boylan also tailors and individualizes student learning to better engage his learners in his courses. For example, he was able to increase student confidence in their drug information skills by integrating students’ societal culture and background into his lectures. Dr. Boylan is an active member of the Pulmonary PRN, the Adult Medicine PRN, and the ACCP Task Force on Career Transitions.
BulmanThe New Investigator Award recognizes an ACCP member who has made a significant impact on an aspect of clinical pharmaceutical science. The awardee must have been a member of ACCP for more than 3 years, must have completed their terminal training or degree less than 6 years previously, and must have a research program with a substantial publication record that includes a programmatic theme or an especially noteworthy single publication. Zackery P. Bulman, Pharm.D., is an assistant professor in the Department of Pharmacy Practice at the University of Illinois Chicago (UIC) College of Pharmacy. He received a B.S. degree in biotechnology from Rochester Institute of Technology and a Pharm.D. degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and completed an NIH-funded fellowship in infectious diseases pharmacology at the University at Buffalo. Bulman’s research program investigates novel pharmacotherapeutic approaches to overcome drug-resistant bacteria and improve patient outcomes.
In recommending Bulman for the 2023 New Investigator Award to the ACCP Board of Regents, the committee wrote:
Dr. Bulman has obtained over $4 million in research grants from the NIH and other competitive funding sources, including an NIH/NIAD R01 as PI to study precision medicine approaches to optimal antibiotic regimen selection specific to a patient’s pathogen using bacterial genotypes. This 5-year award is among the largest R01 awarded to a Pharm.D. He has published 44 peer- reviewed publications, most within the past 3–5 years, and has an h-index of 17; his work has been cited more than 790 times. He has served as first or senior author on original research studies published in top infectious diseases journals such as Lancet Microbe (Impact Factor 86.2), Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, and Clinical Microbiology and Infection. Dr. Bulman has authored two book chapters, provided multiple platform presentations at national and international meetings, and led international consortiums highlighting key areas for future research in infectious diseases. His expertise in the field of antimicrobial resistance and antibiotic selection is reflected in numerous honors and awards, including recognition as a Fellow of the International Society of Antimicrobial Chemotherapy; Editor of mSystems, an American Society for Microbiology journal; and the 2022 UIC Research and Scholar of the Year Rising Star Award.
KufelThe New Clinical Practitioner Award honors a new clinical practitioner who has made outstanding contributions to the health of patients and/or the practice of clinical pharmacy. The awardee must have been a Full Member of ACCP at the time of nomination, as well as a member at any level for a minimum of 3 years; in addition, the awardee must have completed their terminal training or degree less than 6 years previously. Wesley D. Kufel, Pharm.D., BCPS, BCIDP, AAHIVP, is a clinical associate professor of pharmacy practice at State University of New York (SUNY) Binghamton University and has been a clinical pharmacy specialist in infectious diseases at SUNY Upstate University Hospital in Syracuse, New York, since 2017. He received his Pharm.D. degree from the University at Buffalo School of Pharmacy and Pharmaceutical Sciences and completed residency training at SUNY Upstate University Hospital in Syracuse, New York (PGY1), and the University of North Carolina Medical Center in Chapel Hill, North Carolina (PGY2, infectious diseases).
The Awards Committee commented in its report to the ACCP Board of Regents:
Prior to his faculty appointment in 2017, there were no formal infectious diseases consult pharmacy services at his practice site, and since that time, Dr. Kufel has initiated several novel and innovative clinical programs. He has developed or helped optimize numerous pharmacist-led services, including the Staphylococcus aureus bacteremia bundle, an antimicrobial stewardship discharge antibiotic prescription review program, a penicillin allergy management service, electronic antibiotic order sets, and a vancomycin AUC-based dosing and monitoring program. He is also the co-founder and current co-director of the Clinical Research Microcredential Program at SUNY Upstate and was appointed as a member of the Board of Pharmacy Specialties BCIDP specialty council (2023–2025). He was awarded the 2022 New York State ACCP Clinical Practitioner Award as well as the 2021 New York State Council of Health-System Pharmacists New Practitioner Award.
Kufel is also actively engaged in research and scholarship. At the time of his nomination, he had published over 45 peer-reviewed articles and held an h-index of 15 according to Google Scholar. In addition, he has received almost $200,000 in extramural grant funding to support his various clinical research initiatives.
Kane-GillThe ACCP Therapeutic Frontiers Lecture Award recognizes an individual, including ACCP member and nonmember nominees, who has made outstanding contributions to pharmacotherapeutics in their field. Among the criteria for this award is the broad acknowledgment that the recipient is currently considered at the leading edge of therapeutic research. Sandra L. Kane-Gill, Pharm.D., M.Sc., FCCP, FCCM, is a tenured professor at the University of Pittsburgh School of Pharmacy. She is also a member of the graduate faculty and holds a secondary appointment at the Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh School of Medicine. Kane-Gill is known nationally and internationally for her sustained track record of innovative, cutting-edge research in the fields of critical care medicine, nephrology, and medication safety.
Dr. Mitchell Buckley,https://www.accp.com/images/report/0923/1957410_Kane-Gill.png critical care clinical pharmacy specialist at Banner University Medical Center Phoenix, wrote in his letter of support:
Dr. Kane-Gill is considered a leading contributor and expert in her fields of study, distinctly demonstrated from her research and scholarship accolades. Overall, she has published over 180 articles including original research relating to critical care pharmacotherapy with a focus on medication safety and nephrotoxin stewardship. The aggregate financial research funding at the national level is impressive. She has been awarded more than $8.5 million in federal funding in the capacity as Principal Investigator, while also securing an additional $4.4 million as a co-investigator. She is internationally recognized as a leading contributor in pharmacotherapy directly impacting patient safety. Expertscape, Inc., cited her as the top 1% of scholars with expertise in medication safety globally. Furthermore, she was the visionary leader conceptualizing the idea and executing the published work of the Society of Critical Care Medicine (SCCM)’s inaugural clinical practice guidelines on medication safety in the intensive care unit (Kane-Gill SL, et al. Clinical practice guideline: safe medication use in the ICU. Crit Care Med 2017;45:e877-e915. PMID: 28816851).
Dr. Amy L. Dzierba, PGY2 critical care pharmacy residency director and critical care clinical pharmacist at NewYork-Presbyterian Hospital, added in her letter of support:
As a result of Dr. Kane-Gill’s transformative research and international reputation she is one of three pharmacists serving as an expert within a multi-professional team for the Acute Disease Quality Initiative (ADQI) Conferences leading to several publications. Her publication in Nature Reviews Nephrology, cited over 600 times since its publication, describes AKI and considerations for medical management and monitoring that could prevent patients from progressing to chronic kidney disease. Another ADQI publication she co-authored appeared in JAMA Network Open and has been cited 71 times since publication. This important work changed the schema for defining and categorizing AKI to include subclinical AKI, which occurs when a patient is functional biomarker negative but damage biomarker positive.
Dr. Amy Seybert, dean and professor of pharmacy and therapeutics, and Dr. Pamela L. Smithburger, associate professor of pharmacy and therapeutics, University of Pittsburgh School of Pharmacy, expressed in their letter of support:
We would be remiss to end without mentioning her passion for educating the next generation of scientists and clinicians. Not only does Dr. Kane-Gill strive to produce meaningful impacts on patient safety through research, she also carries this dedication to the classroom. The true success of a researcher is to share their experiences through publication and teaching. She is able to apply many of her research publications to the education of future pharmacists and other health care professionals by using medication safety examples throughout her coursework. Dr. Kane-Gill is actively involved in residency training at the University of Pittsburgh and University of Pittsburgh Medical Center. To date, she has trained about 1000 residents and personally mentored 56 residents on projects resulting in 30 peer-reviewed publications. Additionally, she has mentored 8 masters students and 3 PhD students. Currently she is the major advisor to 5 PhD students. Her current doctoral candidate student received an NIAID Loan Repayment Grant to advance research for the management of patients with antibiotic allergies using health information technology. Dr. Kane-Gill’s work with learners in pharmacy further extends the impact and sustainability of her medication safety research.
Kane-Gill has received several prestigious honors and awards, including the ASHP Literature Award for Sustained Contributions, the ASHP Award for Innovation in Pharmacy Practice, SCCM’s Clinical Pharmacy and Pharmacology Section Medication Safety Award, and the ACCP Critical Care PRN Achievement Award. She received ACCP Fellow recognition in 2009 and has served on numerous ACCP committees throughout her tenure as a member. At the time of her nomination, Kane-Gill had published 178 peer-reviewed articles, 200 abstracts, and 18 invited papers; written 18 book chapters; and given 130 national/international presentations. Her Therapeutic Frontiers Lecture, “Expanding Our Understanding and Stewardship of Drug-Related Kidney Disease,” will be delivered during the aforementioned ACCP Awards and Recognition Ceremony.
Shogbon NwaeseiThe ACCP Education Award recognizes an ACCP member who has made substantial and outstanding contributions to clinical pharmacy education at either the professional or postgraduate level. Angela Shogbon Nwaesei, Pharm.D., BCPS, is a clinical associate professor of pharmacy practice at Mercer University College of Pharmacy and an internal medicine clinical pharmacist at Emory Decatur Hospital. Nwaesei is an innovator who has developed interprofessional education programs for audiences that span the health care field, including medical, nursing, and pharmacy students. Her innovations have involved structured approaches to patient-based pharmacotherapy notes, oral assessments in didactic courses, and use of standardized patients for developing student pharmacists’ information-gathering skills. Nwaesei’s teaching also extends internationally to Nigeria, where she has established an international training workshop on pharmacotherapy and an international web-based preceptor development program.
Dr. Teresa Pounds, executive board member of the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas, wrote in her letter of support:
As a board member of the Clinical Pharmacy Development Consortium, Dr. Shogbon Nwaesei worked diligently to aid with planning and delivering continuing education programs towards the advancement of pharmacy education and clinical practice in Nigeria. Specifically, she worked with the leadership team to plan and deliver the first International Training Workshop on Pharmacotherapy - Best Clinical Practices at the University of Benin, Nigeria in which she presented several continuing education lectures. Through this 5-day intensive hands-on case-based training workshop, Dr. Shogbon Nwaesei contributed to the education of pharmacists from across the county, towards the goal of the program to build utilizable skills, knowledge and competence in pharmacotherapy of disease management in patient care settings.
Most recently, Dr. Shogbon Nwaesei led efforts towards the design, development and delivery of a web-based international preceptor development program to help foster the preparation of Nigerian pharmacy faculty and preceptors to precept students in the newly implemented Doctor of Pharmacy degree program in Nigeria. She worked collaboratively with other team members towards the successful delivery of this program to over 90 participants from several different states in Nigeria. Dr. Shogbon Nwaesei also continues to be an invited speaker at the University of Ilorin (Nigeria) Teaching Hospital Pharmacy Department Clinical Meeting virtual seminar, contributing to the education of over 80 participants from pharmacy and medical practices on clinical practice–based topics. Overall, Dr. Shogbon Nwaesei has displayed exemplary leadership skills and dedication to giving back to the profession, even on a global scale towards the education of health care practitioners and students, and advancement of pharmacy education and clinical practice.
Dr. Joy Nwoke from Baptist Hospitals of Southeast Texas wrote:
Dr. Nwaesei understands that a better tomorrow for pharmacy practice and emerging pharmacists begins with education. A piece of advice she left with me that I continually reflect on is, “Maximize every opportunity to grow in your knowledge, understanding, and application of information learned to prepare yourself to optimally care for your patients.” She embodies the advice she shares by continually being a trailblazer in maximizing every opportunity to grow, as seen in her consistent dedication to continuing education programs on local, national, and international scales and leadership in developing international continuing education programs in Nigeria.
At the time of her nomination, Nwaesei had completed 37 continuing education presentations at local, national, and international meetings. She has received numerous awards and honors, including the Distinguished Educator Award and Excellence in Service Award at Mercer University College of Pharmacy and the Georgia Society of Health-System Pharmacists Pharmacoeconomics Research Award.
PastakiaThe ACCP Clinical Practice Award is given to a College member who has made substantial and outstanding contributions to clinical pharmacy practice. Criteria considered in identifying potential candidates include exceptional leadership in developing innovative clinical pharmacy services and sustained excellence in providing them. Sonak Pastakia, Pharm.D., Ph.D., MPH, FCCP, is a professor at Purdue University College of Pharmacy and a consultant with Heart to Heart International – Helping Build Healthy Communities and serves as a member of the Purdue Global Advisory Board, the ME (Myalgic Encephalomyelitis) Action Medical Advisory Board, and the Direct Relief Medical Advisory Board.
Internationally, Pastakia has made a significant impact in Kenya by establishing and expanding pharmacy services there. He is part of AMPATH (Academic Model Providing Access to Healthcare) at Purdue University. He spends 10–11 months each year in Kenya, implementing a wide variety of programs, including a rural diabetes and chronic disease management program, which now serves over 40,000 patients and has screened over 100,000 people. His work also includes a community-based care delivery program that integrates economic development with care delivery in remote, rural areas; a pharmacy distribution system that provides antiretroviral medications to more than 200,000 persons living with HIV at over 500 satellite clinics throughout western Kenya; an anticoagulation monitoring and treatment program for over 4500 patients; and a supply chain system for essential medications at over 76 sites serving a population of more than 8 million people.
Dr. Tina Tran, assistant professor of pharmacy practice at Temple University School of Pharmacy, commented on Pastakia’s impact on the practice of clinical pharmacy in her letter of support:
Not only has he impacted the health of patients for the better through his clinical pharmacy services, Dr. Pastakia has also inspired a generation of young pharmacists, leaders, and policy makers to continue the fight for health equity and to always keep our patients, especially those who are disadvantaged and marginalized, at the forefront and center of our profession. Dr. Pastakia once said: “The primary drivers of our success focus on a unified pursuit toward a singular goal of increasing opportunities for underserved populations. Our approach is not confined by the typical boundaries of pharmacy practice but instead limited only by our creativity and passion for serving populations with limited opportunities.” The products of his work exemplify a selfless dedication to his patients and to the profession of pharmacy.
Pastakia has received numerous awards, including the Albert B. Prescott Pharmacy Leader Award, the Jefferson Science Fellowship Award, and the APhA-APPM Distinguished Achievement in Pharmacy Practice Award. At the time of his nomination, he had published more than 100 publications and received multiple multimillion-dollar grants. Pastakia received ACCP Fellow recognition in 1994.
PaiRussell R. Miller was the founding editor of the College’s journal Pharmacotherapy. The Russell R. Miller Award is presented in recognition of substantial contributions to the literature of clinical pharmacy, thereby advancing both clinical pharmacy practice and rational pharmacotherapy. Manjunath (Amit) P. Pai, Pharm.D., is a tenured professor and chair of the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy. At the time of his nomination, Pai had written or cowritten more than 181 peer-reviewed publications and three books and was the lead author on two chapters in Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Google Scholar (accessed January 11, 2023) notes that his work has resulted in 7290 citations; he has an h-index of 39 and an i10-index of 103.
In his letter of nomination, Dr. Bruce A. Mueller, professor of clinical pharmacy at the University of Michigan College of Pharmacy, remarked on the impact of Pai’s papers for practicing pharmacists and researchers:
Dr. Pai is publishing in the highest-impact clinical journals (Antimicrobial Agents and Chemotherapy, Pharmacotherapy, Clinical Cancer Research, Clinical Pharmacokinetics, etc.) and also the best basic science biomedical journals (Molecular Pharmaceutics, AAPS Journal, etc.). His papers have been very impactful to practicing pharmacists. They have influenced FDA guidance and, of course, he has co-authored the latest vancomycin practice guidelines. With respect to my own areas of research and practice, I would say that the most influential papers that he has published in my field are the following:
- Pai MP. Estimating the glomerular filtration rate in obese adult patients for drug dosing. Adv Chronic Kidney Dis 2010;17:e53-e62.
- Crass RL, Rodvold KA, Mueller BA, Pai MP. Renal dosing of antibiotics: are we jumping the gun? Clin Infect Dis 2019;68:1596-602.
- Patel N, Pai MP, Rodvold KA, et al. Vancomycin: we can’t get there from here. Clin Infect Dis 2011;52:969-74.
Dr. Julie Ann Justo, associate professor at the University of South Carolina College of Pharmacy and infectious diseases clinical pharmacy specialist at Prisma Health Richland Hospital, commented on Pai’s ability to simplify complex concepts for real-world bedside application:
He is also one of the absolute best scientific writers when it comes to simplifying complex mathematical concepts and translating them for practical, real-world application by bedside clinicians. I assign my ID physician fellows to read his publication on the Sawchuk-Zaske method versus Bayesian method for vancomycin AUC estimation in order to help them understand how to determine their own vancomycin exposure goals for their patients (Adv Drug Deliv Rev 2014;77:50-7. PMID 24910345). I’ve also used that same publication to teach hundreds of pharmacy students and practicing pharmacists about the merits of AUC estimation for vancomycin dosing from as early as 2014 – years before the final dosing guidelines were published. Dr. Pai continues to advance our field with his current work to remove descriptors of race for predictive models of renal function and other body composition features.
Pai serves on the editorial boards of the Journal of Clinical Pharmacology, Diagnostic Microbiology and Infectious Diseases, Antimicrobial Agents and Chemotherapy, and Pharmacotherapy. He is a frequent manuscript reviewer for Antimicrobial Agents and Chemotherapy and Pharmacotherapy. Pai has previously received prestigious honors and awards, including “Excellence in Achievement” recognition from the American College of Clinical Pharmacology, the Pharmacotherapy Paper of the Year award from the Society of Infectious Diseases Pharmacists, the Preceptor of the Year and Researcher of the Year awards from the Albany College of Pharmacy and Health Sciences, and the Regulatory Science Excellence Award, Renal Drug Dosing Group from the FDA’s Center for Drug Evaluation and Research.
PattersonRobert M. Elenbaas served as ACCP’s founding executive director from 1986 through 2003. During his 17-year tenure, he exemplified the characteristics of a servant-leader committed to the advancement of clinical pharmacy and ACCP. The Elenbaas Service Award is given only when a particularly noteworthy candidate is identified in recognition of outstanding contributions to the vitality of ACCP or to the advancement of its goals that are well above the usual devotion of time, energy, or material goods. Prior to his retirement, J. Herbert Patterson, Pharm.D., FCCP, was a professor and chair at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, and a research professor of medicine at the University of North Carolina School of Medicine, Division of Cardiology.
Dr. Robert J. DiDomenico, associate professor at the University of Illinois Chicago College of Pharmacy, wrote in his letter of support:
Dr. Patterson’s service to ACCP is noteworthy. Since 1985, Dr. Patterson has been a member of numerous ACCP committees and has displayed the courage to lead – a core value for ACCP – in many of these activities. He has been a member of the Programming Committee (Annual and Spring meetings) on five separate occasions, serving in leadership roles as Vice Chair (1995) and Chair (1996). His service to ACCP also includes membership on both the Awards (1998) and Nominations (2011–2013) Committees, allowing Dr. Patterson to promote and support other members of ACCP, one of his passions.
Dr. Patterson’s leadership within ACCP has been recognized by others, leading to various elected positions and awards. From 1996–1998, Dr. Patterson was elected and served as the Cardiology Practice and Research Network (PRN) Chair-Elect and Chair, serving as recognition for his contributions and leadership among other cardiovascular clinical pharmacy specialists. Between 1999–2002, Dr. Patterson was elected and served as ACCP Secretary, demonstrating his level of recognition and leadership to the entire organization. For his contributions to ACCP, Dr. Patterson was honored as a Fellow of ACCP (FCCP) in 1994. In recognition of his scholarly success and professional leadership, Dr. Patterson was awarded the Lifetime Achievement Award from the ACCP Cardiology PRN in 2020.
Dr. Jo Ellen Rodgers, professor at the UNC Eshelman School of Pharmacy, shared in her letter of support:
Dr. Patterson has had a sustained commitment to not only disseminating advancements in the management of patients with heart failure (HF), but also developing the next generation of practitioners and researchers to do the same. He has trained more than 20 fellows and graduate students and maintained a commitment to the development of future practitioners and researchers in HF. His efforts have served as an inspiration to generations of clinical pharmacists and pharmacy researchers, as well as clinicians and researchers in other health care disciplines…. Across all health care disciplines, the number of individuals influenced by Dr. Patterson who have gone on to become leaders in academic or pharmaceutical industry truly cannot be counted. Truly, he planted to seed, in the minds of pharmacists and other clinician-scientists, that pharmacists should be at the table leading clinical research initiatives. The ultimate impact of his role in advancing clinical research in this manner and the subsequent impact on patient care is immeasurable.
At the time of his nomination, Patterson had published over 200 peer-reviewed publications, abstracts, and book chapters within well-respected, high-impact cardiovascular journals, including the Journal of the American College of Cardiology, American Heart Journal, Circulation, Circulation: Heart Failure, Journal of Cardiac Failure, and Pharmacogenetics and Genomics. He has served as a series editor for CardSAP since its initial release in 2019. Patterson received ACCP Fellow recognition in 1994.
Members of the 2023 ACCP Awards Committee were Kristi Kelley (chair), Nancy Shapiro (vice chair), Brian Hemstreet (secretary), Scott Bolesta, Alexandre Chan, Melanie Claborn, Patrick Dougherty, Amy Fabian, Christine Groth, Paul Gubbins, Young Lee, Cynthia Nguyen, Tanvi Patil, Golden Peters, Ann Philbrick, Jennifer Phillips, Chasity Shelton, Paul Stranges, Stephanie Tchen, and Kathleen Vest.